This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Hikma Launches Denosumab Biosimilars ENOBY And XTRENBO

On January 19, 2026, Hikma announced the U.S. launch of ENOBY (denosumab-qbde) and XTRENBO (denosumab-qbde)—denosumab biosimilars referencing Amgen's...

United States Healthcare

GP

Goodwin Procter LLP

FDA Launches Manufacturing PreCheck Pilot Program To Boost U.S. Drug Production

FDA recently launched a Manufacturing PreCheck Pilot Program ("Pilot Program" or "PreCheck") designed to strengthen the domestic pharmaceutical and biologics supply chain by reducing regulatory barriers and increasing predictability in the drug manufacturing inspection and approval process.

United States Healthcare

LB

Lewis Brisbois Bisgaard & Smith LLP

HIPAA Enforcement: A Look Ahead At 2026 Informed By 2025's Inflection Points

The healthcare ecosystem has closed the book on a volatile 2025, and HIPAA enforcement has moved into 2026 with sharper edges, wider apertures, and higher stakes.

United States Healthcare

FH

Foley Hoag LLP

The Regulatory Roadmap: Five Critical Questions For Evaluating Regulatory Risk For Longevity Companies

Companies operating in this space range from biotech innovators targeting the biology of aging, to digital health platforms delivering personalized insights, to consumer brands focused...

United States Healthcare

AF

ArentFox Schiff

Benesch's Dental/DSO Intelligence Monthly Report: February 2026

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

False Claims Act Year In Review

United States Healthcare

W

WilmerHale

Regulatory Horizons: Cybersecurity And FDA Regulated Companies (Podcast)

United States Healthcare

B

BakerHostetler

New York May Adopt Limited Policy Expanding Coronary Interventions In Ambulatory Surgical Centers

United States Healthcare

GT

Greenberg Traurig, LLP

Medicare Advantage At An Inflection Point: From Coding Arbitrage To Value Competition

United States Healthcare

AM

Alvarez & Marsal

Minor Records, Major Problems: Navigating Federal And State Mandates Regarding Parental Access To Children's Health Records

United States Healthcare

B

BakerHostetler

FDA Cosmetics Compliance: Understanding FDA Records Access Under MoCRA

United States Healthcare

KM

Katten Muchin Rosenman LLP

Age Limits On Bodybuilding, Weight-Loss Supplements Survive First Amendment Challenge

United States Healthcare

HK

Holland & Knight

Health Law: Broad Practice On The Cutting Edge

United States Healthcare

FF

Farrell Fritz, P.C.

FDA Tightens The Belt On GLP-1 Compounding, Escalating Threat Of Enforcement

United States Healthcare

PL

Polsinelli LLP

See more

Webinars

See More

Recorded on 20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Hikma Launches Denosumab Biosimilars ENOBY And XTRENBO

On January 19, 2026, Hikma announced the U.S. launch of ENOBY (denosumab-qbde) and XTRENBO (denosumab-qbde)—denosumab biosimilars referencing Amgen's...

United States Healthcare

GP

Goodwin Procter LLP

PBM Reform Cheat Sheet: Chart Comparing The Recent Rules For Group Plans

Within a one-week period, there were two actions at the federal level to increase pharmacy benefits manager (PBM) transparency. The Consolidated Appropriations Act of 2026 (CAA 2026) and Department of Labor...

United States Employment

FL

Foley & Lardner

FDA Launches Manufacturing PreCheck Pilot Program To Boost U.S. Drug Production

FDA recently launched a Manufacturing PreCheck Pilot Program ("Pilot Program" or "PreCheck") designed to strengthen the domestic pharmaceutical and biologics supply chain by reducing regulatory barriers and increasing predictability in the drug manufacturing inspection and approval process.

United States Healthcare

LB

Lewis Brisbois Bisgaard & Smith LLP

The Regulatory Roadmap: Five Critical Questions For Evaluating Regulatory Risk For Longevity Companies

United States Healthcare

AF

ArentFox Schiff

Benesch's Dental/DSO Intelligence Monthly Report: February 2026

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Regulatory Horizons: Cybersecurity And FDA Regulated Companies (Podcast)

United States Healthcare

B

BakerHostetler

FDA Cosmetics Compliance: Understanding FDA Records Access Under MoCRA

United States Healthcare

KM

Katten Muchin Rosenman LLP

Age Limits On Bodybuilding, Weight-Loss Supplements Survive First Amendment Challenge

United States Healthcare

HK

Holland & Knight

FDA Tightens The Belt On GLP-1 Compounding, Escalating Threat Of Enforcement

United States Healthcare

PL

Polsinelli LLP

See more

Life Sciences, Biotechnology & Nanotechnology

PBM Reform Cheat Sheet: Chart Comparing The Recent Rules For Group Plans

Within a one-week period, there were two actions at the federal level to increase pharmacy benefits manager (PBM) transparency. The Consolidated Appropriations Act of 2026 (CAA 2026) and Department of Labor...

United States Employment

FL

Foley & Lardner

FDA Launches Manufacturing PreCheck Pilot Program To Boost U.S. Drug Production

FDA recently launched a Manufacturing PreCheck Pilot Program ("Pilot Program" or "PreCheck") designed to strengthen the domestic pharmaceutical and biologics supply chain by reducing regulatory barriers and increasing predictability in the drug manufacturing inspection and approval process.

United States Healthcare

LB

Lewis Brisbois Bisgaard & Smith LLP

The Regulatory Roadmap: Five Critical Questions For Evaluating Regulatory Risk For Longevity Companies

Companies operating in this space range from biotech innovators targeting the biology of aging, to digital health platforms delivering personalized insights, to consumer brands focused...

United States Healthcare

AF

ArentFox Schiff

Benesch's Dental/DSO Intelligence Monthly Report: February 2026

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Regulatory Horizons: Cybersecurity And FDA Regulated Companies (Podcast)

United States Healthcare

B

BakerHostetler

Oral Semaglutide And The GLP-1 Compounding Reckoning: From Regulatory Ambiguity To FDA Enforcement, DOJ Referrals, And Novo Nordisk's Case Against Hims & Hers

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Congress Passes Landmark PBM Reform In 2026 Spending Bill

United States Healthcare

M

Mintz

Here We Go Again: Third Round Of Inflation Reduction Act Drugs Listed

United States Healthcare

AV

Axinn Veltrop & Harkrider

Healthy AI: 2025 Year In Review

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

See more

Healthcare

PBM Reform Cheat Sheet: Chart Comparing The Recent Rules For Group Plans

Within a one-week period, there were two actions at the federal level to increase pharmacy benefits manager (PBM) transparency. The Consolidated Appropriations Act of 2026 (CAA 2026) and Department of Labor...

United States Employment

FL

Foley & Lardner

FDA Launches Manufacturing PreCheck Pilot Program To Boost U.S. Drug Production

FDA recently launched a Manufacturing PreCheck Pilot Program ("Pilot Program" or "PreCheck") designed to strengthen the domestic pharmaceutical and biologics supply chain by reducing regulatory barriers and increasing predictability in the drug manufacturing inspection and approval process.

United States Healthcare

LB

Lewis Brisbois Bisgaard & Smith LLP

HIPAA Enforcement: A Look Ahead At 2026 Informed By 2025's Inflection Points

The healthcare ecosystem has closed the book on a volatile 2025, and HIPAA enforcement has moved into 2026 with sharper edges, wider apertures, and higher stakes.

United States Healthcare

FH

Foley Hoag LLP

The Regulatory Roadmap: Five Critical Questions For Evaluating Regulatory Risk For Longevity Companies

United States Healthcare

AF

ArentFox Schiff

Benesch's Dental/DSO Intelligence Monthly Report: February 2026

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

False Claims Act Year In Review

United States Healthcare

W

WilmerHale

Regulatory Horizons: Cybersecurity And FDA Regulated Companies (Podcast)

United States Healthcare

B

BakerHostetler

New York May Adopt Limited Policy Expanding Coronary Interventions In Ambulatory Surgical Centers

United States Healthcare

GT

Greenberg Traurig, LLP

Medicare Advantage At An Inflection Point: From Coding Arbitrage To Value Competition

United States Healthcare

AM

Alvarez & Marsal

See more

Latest Videos

See more

Pay Transparency + The Power Of Preventive Strategies: Episode 3 — Pivoting Toward Preparation In The Life Sciences (Video)

JL

Jackson Lewis P.C.

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

Critical Medical Device Series: Part X Balancing Risk And Innovation: Fraud And Abuse Trends For MedTech (Video)

AP

Arnold & Porter

Strategic Synergy At Atlantic Health: Saad Ehtisham On How Leadership Alignment Fuels Transformation (Video)

AM

Alvarez & Marsal

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Upcoming Events

Peptide Drug Summit 2026

United States Healthcare

FH

Foley Hoag LLP

Pharmaceutical Compliance Congress 2026

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Healthcare Regulation After Loper Bright And Corner Post: Maintaining Compliance In A Post-Chevron World

United States Healthcare

FL

Foley & Lardner

Houston MedTech Rodeo

United States Healthcare

GP

Goodwin Procter LLP

Virtual Forty-Third National HIPAA Summit

United States Healthcare

HK

Holland & Knight

Exploring The Subtleties And Safe Zones Of Off-Label Communications — Part 2

United States Healthcare

FL

Foley & Lardner

From Discovery To Delivery: What The FDA Drug Review Process Means For Rare Disease Patients And Providers

United States Healthcare

HK

Holland & Knight

The Town Hall Table: From State Chapters To The U.S. Capitol

United States Healthcare

HK

Holland & Knight

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More